MAIORANA, SANTINA
 Distribuzione geografica
Continente #
EU - Europa 439
NA - Nord America 323
AS - Asia 88
AF - Africa 3
Totale 853
Nazione #
US - Stati Uniti d'America 323
IT - Italia 105
IE - Irlanda 104
SE - Svezia 80
PL - Polonia 78
CN - Cina 71
FR - Francia 34
BE - Belgio 12
AT - Austria 9
SG - Singapore 9
DE - Germania 8
FI - Finlandia 4
VN - Vietnam 4
DZ - Algeria 3
IN - India 3
GB - Regno Unito 2
MD - Moldavia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
UA - Ucraina 1
Totale 853
Città #
Chandler 109
Dublin 104
Warsaw 78
Nyköping 55
Beijing 43
Messina 35
Princeton 22
Ann Arbor 19
Ashburn 18
Medford 15
Des Moines 11
Montpellier 11
Jacksonville 10
Vienna 9
Brussels 8
Singapore 8
Jinan 6
Rome 5
San Mateo 5
Cagliari 4
Catania 4
Dearborn 4
Dong Ket 4
Palermo 4
Shenyang 4
Taizhou 4
Cambridge 3
Munich 3
Trecastagni 3
Boardman 2
Brussel 2
Cairate 2
Caltagirone 2
Hebei 2
Ningbo 2
Zhengzhou 2
Chisinau 1
Council Bluffs 1
Fuzhou 1
Haikou 1
Hangzhou 1
Hanover 1
Helsinki 1
Houston 1
Hyderabad 1
Jiaxing 1
Lanzhou 1
Leonforte 1
Los Angeles 1
Mainz 1
Nanjing 1
Napoli 1
Nashville 1
New York 1
Norwalk 1
Orsay 1
Paris 1
Riva 1
Rosolini 1
Saint-denis 1
Scordia 1
Southampton 1
Springfield 1
Tianjin 1
Wilmington 1
Totale 651
Nome #
Design, synthesis and biological evaluation of novel inhibitors of human and protozoan proteases 127
Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma cells 86
Design, synthesis and biological evaluation of novel rhodesain inhibitors for the treatment of Human African Trypanosomiasis 81
Development of novel irreversible rhodesain inhibitors as antitrypanosomal agents. 71
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 67
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 59
Development of pyridin-2-one derivatives as non-covalent inhibitors of immunoproteasome 57
Evaluation of curcumin irreversibility 54
Development of novel amides as non covalent inhibitors of immunoproteasome 51
Development of novel peptide-based Michael acceptors as antitrypanosomal agents 51
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 50
null 41
Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis 40
Drug synergism: studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense 29
null 27
null 21
Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment 17
Development of novel amides as noncovalent inhibitors of immunoproteasome 15
Totale 944
Categoria #
all - tutte 3.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.132


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020187 21 5 6 4 1 13 17 15 9 64 20 12
2020/2021175 5 14 36 8 34 30 14 4 15 11 0 4
2021/2022113 4 14 1 7 1 0 2 2 1 26 3 52
2022/2023356 29 44 13 34 19 38 5 27 136 3 7 1
2023/202466 2 14 4 19 2 2 0 4 0 11 1 7
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 944